Authors
Kaima Tsukada, Samuel E Jones, Julius Bannister, Mary-Anne Durin, Iolanda Vendrell, Matthew Fawkes, Roman Fischer, Benedikt M Kessler, J Ross Chapman, Andrew N Blackford
Publication date
2024/2/15
Journal
Molecular Cell
Volume
84
Issue
4
Pages
640-658. e10
Publisher
Elsevier
Description
The Bloom syndrome helicase BLM interacts with topoisomerase IIIα (TOP3A), RMI1, and RMI2 to form the BTR complex, which dissolves double Holliday junctions and DNA replication intermediates to promote sister chromatid disjunction before cell division. In its absence, structure-specific nucleases like the SMX complex (comprising SLX1-SLX4, MUS81-EME1, and XPF-ERCC1) can cleave joint DNA molecules instead, but cells deficient in both BTR and SMX are not viable. Here, we identify a negative genetic interaction between BLM loss and deficiency in the BRCA1-BARD1 tumor suppressor complex. We show that this is due to a previously overlooked role for BARD1 in recruiting SLX4 to resolve DNA intermediates left unprocessed by BLM in the preceding interphase. Consequently, cells with defective BLM and BRCA1-BARD1 accumulate catastrophic levels of chromosome breakage and micronucleation …
Total citations
Scholar articles